HDM1005
Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus
Huadong Medicine · Phase 2 · Recruiting · Enrollment 240
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| HDM1005 dose cohort 1 QW | Obesity or overweight | n/r | n/r | n/r | n/r |
| HDM1005 dose cohort 2 QW | Obesity or overweight | n/r | n/r | n/r | n/r |
| HDM1005 dose cohort 3 QW | Obesity or overweight | n/r | n/r | n/r | n/r |
| HDM1005 dose cohort 4 QW | Obesity or overweight | n/r | n/r | n/r | n/r |
| placebo QW | Obesity or overweight | n/r | n/r | n/r | n/r |